Skip to main content

and
  1. No Access

    Chapter

    Is the Beta-Blocker DL-ZAMI 1305 a Tumor Promoter for Rat Liver?

    A 6-month administration of the beta-adrenoreceptor blocking agent DL-1-(2-nitro-3-methyl-phenoxy)-3-tert-butylamino-propan-2-ol (DL-ZAMI 1305) results in the appearance of metastatic hepatocellular carcinomas...

    T. Zavanella, G. Radaelli, P. Girotti, M. Presta, G. Ragnotti in Chemical Carcinogenesis 2 (1991)

  2. No Access

    Article

    First degree family history of diabetes and risk factors for cardiovascular disease in non-diabetic subjects in the National Telephone Company: A metabolic survey

    The effect of first degree family history of diabetes on known risk factors for cardiovascular disease was evaluated in 4989 non-diabetic employees of the Italian Telephone Company. Family history of diabetes ...

    P. Micossi, G. Gallus, P. Valsania, P. Garancini in European Journal of Epidemiology (1987)